Zimmer Biomet (ZBH) PT Raised to $153 at Needham & Company; Buy on Weakness
Needham & Company raised its price target on Zimmer Biomet (NYSE: ZBH) to $153.00 (from $151.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
